Researchers surveyed medical oncology fellows to assess the perceived impact of abortion restrictions on cancer care and how ...

The HYPOSIB trial supports moderately hypofractionated radiotherapy with simultaneous boost as a standard-of-care option that ...

High-dose radiotherapy “needs the addition of short-term ADT to improve outcomes in intermediate- and high-risk localized ...

Patients who received subcutaneous daratumumab plus bortezomib, lenalidomide, and dexamethasone (VRd) had better outcomes ...

Zachary W. Schulz, a public health historian, compares Kamala Harris's and Donald Trump's records on health care.

Children with ALL who are MRD negative at the end of first consolidation do not require further MRD assessments, researchers say.

Using patient-derived tumor organoids, researchers have identified which therapies may be most effective for individual sarcoma patients.

Rates of late biochemical recurrence and progression to metastasis were “strikingly low” in patients with pT2 stage disease and Gleason scores less than or equal to 3 + 4.

Decitabine plus venetoclax and ponatinib appeared safe and elicited responses in a phase 2 trial of patients with advanced phase CML.

(HealthDay News) — An in-home cognitive behavioral therapy program improves insomnia symptoms in breast cancer survivors, according to a study published in JAMA Network Open.

(HealthDay News) — Most Americans don’t plan to get vaccinated against the flu or COVID-19 this season, according to a survey from the National Foundation for Infectious Diseases (NFID).

(HealthDay News) — A wearable device may improve physical activity, physical function, dyspnea, and pain after lung cancer surgery, according to a study published in JAMA Network Open.